Table 1 Clinical, and virological characteristics of study participants
Sample name used in the study | Age | Sex | Number of year of infection | Number of year of treatment | Treatment | Mean CD4 + T cell counts cells/mm3) | Viral load (copies) |
|---|---|---|---|---|---|---|---|
EC-1 | 50-59 | F | 31 | 1106 | 40 | ||
EC-4 | 50-59 | M | 30 | 647 | 61 | ||
EC-2 | NA | NA | NA | NA | NA | ||
EC-3 | NA | NA | NA | NA | NA | ||
ART-2 | 60-69 | M | 22 | 22 | edurant + kivexa | 693 | <40 |
ART-3 | 60-69 | M | 32 | 21 | atripla | 488 | <40 |
ART-1 | NA | NA | NA | NA | NA | NA | <40 |
